Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Liberty Leaf Holdings was a Canadian public company that primarily operated within the legal cannabis industry, focusing on the medicinal and recreational sectors. The company specialized in acquiring and developing a diverse portfolio of cannabis-related assets, including cultivation facilities, distribution networks, and research initiatives. Key holdings included interests in North Road Ventures, a value-added distributor, and Just Kush, a late-stage cultivation applicant. Beyond production, Liberty Leaf explored the development of cannabinoid-based products for both human and animal health applications. In late 2019, the company underwent a fundamental change of business, transitioning into the mineral exploration sector and subsequently changing its name to Carlyle Commodities Corp.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Liberty Leaf Holdings.